Paula Ragan S.'s most recent trade in X4 Pharmaceuticals Inc was a trade of 2,250,000 Common Stock done . Disclosure was reported to the exchange on Feb. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 2,250,000 | 3,337,386 (20%) | 13% | 0 | Common Stock | |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 169,940 | 1,163,859 (7%) | 1% | 0 | Common Stock | |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.45 per share. | 23 Jan 2025 | 76,473 | 1,087,386 (6%) | 0% | 0.5 | 34,719 | Common Stock |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.39 per share. | 15 Nov 2024 | 31,897 | 993,919 (6%) | 0% | 0.4 | 12,583 | Common Stock |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.56 per share. | 15 Oct 2024 | 31,897 | 1,025,816 (6%) | 0% | 0.6 | 17,926 | Common Stock |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 532,081 | 1,297,149 (8%) | 3% | 0 | Common Stock | |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.55 per share. | 04 Oct 2024 | 239,436 | 1,057,713 (6%) | 1% | 0.5 | 131,522 | Common Stock |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.88 per share. | 11 Mar 2024 | 49,678 | 765,068 (4%) | 0% | 0.9 | 43,856 | Common Stock |
| X4 Pharmaceuticals Inc | Paula Ragan S. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 1,189,578 | 1,189,578 | - | - | Stock Appreciation Right | |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.01 per share. | 12 Feb 2024 | 21,695 | 814,746 (5%) | 0% | 1.0 | 21,892 | Common Stock |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.92 per share. | 23 Jun 2023 | 6,724 | 543,797 (3%) | 0% | 1.9 | 12,910 | Common Stock |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.23 per share. | 15 Jun 2023 | 6,724 | 550,521 (3%) | 0% | 2.2 | 14,995 | Common Stock |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.95 per share. | 31 May 2023 | 6,292 | 557,245 (3%) | 0% | 1.9 | 12,269 | Common Stock |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.84 per share. | 10 Mar 2023 | 49,678 | 563,537 (3%) | 0% | 0.8 | 41,730 | Common Stock |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.93 per share. | 13 Feb 2023 | 21,695 | 613,215 (3%) | 0% | 0.9 | 20,176 | Common Stock |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2022 | 3,438,335 | 3,438,335 | - | - | Stock Appreciation Right | |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 17 Aug 2022 | 13,448 | 634,910 (3%) | 0% | - | Common Stock | |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 24 Jun 2022 | 6,724 | 648,358 (4%) | 0% | - | Common Stock | |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 16 Jun 2022 | 6,724 | 655,082 (4%) | 0% | - | Common Stock | |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.21 per share. | 03 Jun 2022 | 6,292 | 661,806 (4%) | 0% | 1.2 | 7,613 | Common Stock |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 220,789 | 668,098 (4%) | 1% | 0 | Common Stock | |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 11 Feb 2022 | 21,695 | 447,309 (2%) | 0% | - | Common Stock | |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.10 per share. | 17 Aug 2021 | 13,448 | 469,004 (2%) | 0% | 5.1 | 68,585 | Common Stock |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.78 per share. | 15 Jul 2021 | 13,448 | 482,452 (2%) | 0% | 5.8 | 77,729 | Common Stock |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 44,826 | 495,900 (3%) | 0% | 0 | Common Stock | |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 44,826 | 451,074 (2%) | 0% | 0 | Common Stock | |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.50 per share. | 02 Jun 2021 | 2,400 | 406,248 (2%) | 0% | 9.5 | 22,800 | Common Stock |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.41 per share. | 01 Jun 2021 | 4,104 | 408,648 (2%) | 0% | 9.4 | 38,619 | Common Stock |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 8.33 per share. | 03 May 2021 | 2,400 | 412,752 (2%) | 0% | 8.3 | 19,992 | Common Stock |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.17 per share. | 05 Apr 2021 | 2,400 | 415,152 (2%) | 0% | 9.2 | 22,008 | Common Stock |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2021 | 144,629 | 417,552 (2%) | 0% | 0 | Common Stock | |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.74 per share. | 02 Mar 2021 | 2,400 | 272,923 (1%) | 0% | 9.7 | 23,376 | Common Stock |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.88 per share. | 02 Feb 2021 | 2,400 | 275,323 (1%) | 0% | 7.9 | 18,912 | Common Stock |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 05 Jan 2021 | 2,400 | 277,723 (1%) | 0% | 7 | 16,800 | Common Stock |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 23 Dec 2020 | 4,800 | 280,123 (1%) | 0% | 7 | 33,600 | Common Stock |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 05 Oct 2020 | 1,797 | 284,923 (1%) | 0% | 7 | 12,579 | Common Stock |
| X4 Pharmaceuticals Inc | Paula S. Ragan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 02 Oct 2020 | 603 | 286,720 (1%) | 0% | 7 | 4,221 | Common Stock |